Shandong Xinhua Pharmaceutical Co (SZSE:000756) Total Stockholders Equity : ¥4,553 Mil (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Shandong Xinhua Pharmaceutical Co Total Stockholders Equity?

Shandong Xinhua Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ¥4,553 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Shandong Xinhua Pharmaceutical Co's Book Value per Share for the quarter that ended in Dec. 2023 was ¥6.75. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Shandong Xinhua Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.30.

Shandong Xinhua Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Shandong Xinhua Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Xinhua Pharmaceutical Co Total Stockholders Equity Chart

Shandong Xinhua Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

2,969.03

3,223.79

3,467.94

4,126.27

4,553.10

Shandong Xinhua Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															4,126.27	4,323.96	4,330.82	4,479.38	4,553.10

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Shandong Xinhua Pharmaceutical Co's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4553.104	-	0)	/	674.683
	=	6.75

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Shandong Xinhua Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(557.714	+	800.979)	/	4553.104
	=	0.30

Shandong Xinhua Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shandong Xinhua Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (SZSE:000756) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

00719:Hong Kong XIN:Germany

Address

No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo City, Shandong, CHN, 255086

Website

http://www.xhzy.com

Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Headlines

No Headlines